Abstract
In June 1981 the initial reports of the occurrences of Pneumocystis carinii pneumonia and Kaposi’s sarcoma in previously healthy homosexual men [1, 2] heralded the beginning of the epidemic now known as the acquired immune deficiency syndrome (AIDS). Shortly thereafter it was recognized that the particular populations found to be at risk for the development of AIDS — homosexual or bisexual men, intravenous drug users, hemophiliacs, and people who have received blood transfusions or other blood products — were also known to be at risk for infection with hepatitis B (HBV).
This manuskript was supported by the Howard Gilman Foundation and the Samuel and May Rudin Foundation, both of New York.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gottlieb MS, Schroff R, Schanker HM et al. (1981) Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency. N Engl J Med 305:1425
Friedman-Kien AE, Laubenstein L, Marmor M et al. (1981) Kaposi’s sarcoma and Pneumocystis pneumonia among homosexual men – New York and California. MMWR 30: 250–252
Barre-Sinoussi F, Chermann JC, Rey F et al. (1983) Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871
Popovic M, Sarngadharan MG, Read E, Gallo RC (1984) Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224: 497–500
Centers for Disease Control (1987) Recommendations for prevention of HIV transmission in health-care settings. MMWR 35 [Suppl 2S]: 3–18
Ward JW, Deppe DA, Samson S et al. (1987) Risk of human immunodeficiency virus infection from blood donors who later developed the acquired immunodeficiency syndrome. Ann Intern Med 106: 61–62
Curran JW, Morgan MM, Hardy AM et al. (1985) The epidemiology of AIDS: current status and future prospects. Science 229: 1352–1357
Friedland CH, Klein RS (1987) Transmission of the human immunodeficiency virus. N Engl J Med 317:1125–1135
Martin LS, McDougal JS, Loskoski SL (1985) Disinfection and inactivation of the human T lymphotropic virus type III/lymphadenopathy-associated virus. J Infect Dis 152: 400–403
Spire B, Barre-Sinoussi F, Montagnier L, Chermann JC (1984) Inactivation of lymphadenopathy associated virus by chemical disinfectants. Lancet: 899–901
Resnick L, Veren K, Salahuddin SZ, Tondreau S, Markham PD (1986) Stability and inactivation of HTLV-III/LAV under clinical and laboratory environments. JAMA 255: 1887–1891
Martin LS, Loskoski SL, McDougal JS (1987) Inactivation of human T-lymphotropic virus type III/lymphadenopathy-associated virus by formaldehyde-based reagents. Appl Environ Microbiol 53: 708–709
Kaplan JC, Crawford DC, Durno AG, Schooley RT (1987) Inactivation of human immunodeficiency virus by betadine. Infect Control 8: 412–414
Hicks DR, Martin LS, Gretchell JP et al. (1985) Inactivation of HTLV-III/LAV-infected cultures of normal human lymphocytes by nonoxynol-9 in vitro. Lancet ii: 1422
Klein RJ, Buimovici-Klein E, Ong KR, Czelusniak SM, Lange M, Friedman-Kien AE (1987) Inactivation of human immunodeficiency, herpes simplex, and vaccinia viruses by sodium oxychlorosene. Lancet ii: 281–282
Prince AM, Horowitz B, Brotman B (1986) Sterilisation of hepatitis and HTLV-III viruses by exposure to Tri(n-BUTYL)phosphate and sodium cholate. Lancet 706-710
Centers for Disease Control (1985) Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in the workplace. MMWR 34: 681–686, 691-695
McCray E (1986) The Cooperative needlestick surveillance group. Occupational risk of the acquired immunedeficiency syndrome among health-care workers. N Engl J Med 314:1127–1132
Henderson DK, Saah AJ, Zak BJ, Kaslow RA, Lane C et al. (1986) Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers. Ann Intern Med 104: 644–647
Gerberding JL, Bryant-LeBlanc CE, Nelson K, Moss AR, Osmond D et al. (1987) Risk of transmitting the human immunodeficiency virus, cytomegalovirus, and hepatitis B virus to health care workers exposed to patients with AIDS and AIDS-related conditions. J Infect Dis 156:1–8
McEvoy M, Porter K, Mortimer P, Simmons N, Shanson D (1987) Prospective study of clinical, laboratory, and ancillary staff with accidental exposures to blood or other body fluids from patients infected with HIV. Br Med J [Clin Res] 294:1595–1597
Klein RS, Phelan A, Freeman K et al. (1987) Low occupational risk of human immunodeficiency virus infection among dental professionals. N Engl J Med 318: 86–90
Anonymous (1984) Needlestick transmission of HTLV-III from a patient infected in Africa. Lancet: 1376-1377
Oksenhendler E, Harzie M, Le Roux JM, Rabian C, Clauvel JP (1986) HIV infection with seroconversion after a superficial needlestick injury to the finger. N Engl J Med 515: 582
Neisson-Vernant C, Arfi S, Mathez D, Leibowitch J, Monplaisir N (1986) Needlestick HIV seroconversion in a nurse. Lancet 2: 814
Centers for Disease Control (1987) Update: human immunodeficiency virus infections in health care workers exposed to blood of infected patients. MMWR 36: 285–289
Centers for Disease Control (1986) Apparent transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus from a child to a mother providing health care. MMWR 35: 76–79
Grint P, McEvoy M (1985) Two associated cases of the acquired immune deficiency syndrome (AIDS). PHLS Commun Dis Rep 42: 4
Weiss SH, Goedert JJ, Gartner S et al. (1988) Risk of human immunodeficiency virus (HIV-1) infection among laboratory workers. Science 239: 68–71
Hessol NA, Rutherford GW, O’Malley PM et al. (1987) The natural history of human immunodeficiency virus infection in a cohort of homosexual and bisexual men (Abstract). In: Abstracts from the III international conference on AIDS, June 1-5, 1987, Washington, DC, p 1
Centers for Disease Control (1986) Recommended infection-control practices for dentistry. MMWR 35: 237–242
Centers for disease control (1986) Recommendations for providing dialysis treatment to patients infected with Human T-lymphotropic virus type III/lymphadenopathy-associated virus. MMWR 35: 376–383
Centers for disease control (1986) Human T-lymphotropic virus type III/lymphadenopathy-associated virus: agent summary statement. MMWR 35: 540–549
Centers for disease control (1986) Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. MMWR 35: 221–223
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Saltzman, B.R., Friedman-Kien, A.E. (1988). Inactivation of HIV and Safety Precautions for the Workplace. In: Schmid, L., Senn, HJ. (eds) AIDS-Related Neoplasias. Recent Results in Cancer Research, vol 112. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83470-7_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-83470-7_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83472-1
Online ISBN: 978-3-642-83470-7
eBook Packages: Springer Book Archive